CC-90005

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameCC-90005
Drug Alias NameCC-90005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C theta inhibitors
TargetsProtein kinase C theta
Therapy Area/IndicationsParapsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsParapsoriasis

Other Information

ATC CodeN/A
Related LinksN/A